Bio-Rad Laboratories
BIO
#1178
Rank
$14.00 B
Marketcap
$478.96
Share price
0.64%
Change (1 day)
-15.18%
Change (1 year)
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.

P/E ratio for Bio-Rad Laboratories (BIO)

P/E ratio as of January 2023 (TTM): -2.37

According to Bio-Rad Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.37344. At the end of 2021 the company had a P/E ratio of 5.30.

P/E ratio history for Bio-Rad Laboratories from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
20215.3016.25%
20204.56-27.43%
20196.28-67.07%
201819.1-69.17%
201761.8-67.44%
2016190429.94%
201535.8-8.46%
201439.1-14.5%
201345.8160.61%
201217.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
23.1-1,073.35%๐Ÿ‡บ๐Ÿ‡ธ USA
32.0-1,447.95%๐Ÿ‡บ๐Ÿ‡ธ USA
37.1-1,661.83%๐Ÿ‡บ๐Ÿ‡ธ USA
42.5-1,892.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-15.1 534.13%๐Ÿ‡บ๐Ÿ‡ธ USA
28.9-1,318.10%๐Ÿ‡บ๐Ÿ‡ธ USA
28.2-1,286.73%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.